Novosynth Pharmaceuticals Llc

Country/Region: United States     State/Province: New Jersey

Main Products: Insulin

Company Introduction
NovoSynth Pharmaceuticals is a knowledge based and acustomer focused company, supporting clients across the value chain: R&D, Manufacturing, Sales & Marketing. We enable the faster / more effective advancement of our clients commercialization efforts: (i) Open doors to collaborations across the value chain, globally (ii) Supporting CMC and Supply-Chain management activities (iii) Facilitate the introduction of products and services to new markets. We have presence in US, Europe & China and direct access to pharmaceutical suppliers and manufacturers. Our network of chemical suppliers and service providers can work together to meet our customers speed to market objectives and deliver quality, security of supply and cost competitiveness
Company Overview

Business Type: Exporter, Retailer

Year Established: 2010

Employees: 5 - 10 People

Plant Area: Below 1000 sqm

Business Information

Main Markets: South America 8% Africa 11% Eastern Asia 9% Domestic Market 11% North America 9% Eastern Europe 10% Southern Europe 8% Mid East 9% Northern Europe 8% Oceania 17%

Trade Capacity: FOB, CFR, CPT

Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered

Nearest Port: Newark

Trade & Financial Information

Annual Revenue: US$50 Million - US$100 Million

Total Revenue: Above US$100 Million

Export Revenue: US$1 Million - US$2.5 Million

Annual Output: US$1 Million - US$2.5 Million

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 61% - 70%

Payment Modes: USD, EUR, HKD

Lead Time: 17 days

Import/Export Mode: Professional Association

Product Showcase
insulin

CL-Link > Health & Medicines in United States Health & Medicines in New Jersey Medicines in United States Medicines in New Jersey Beta Glucan in United States Beta Glucan in New Jersey